SCHEDULE 13G/A: NeuroOne Medical Technologies: Key Investors Maintain Passive Stakes Below 5%
Beneficial Ownership Report
An amended Schedule 13G filing reveals that Manchester Explorer, L.P., Manchester Management Company, LLC, Manchester Management PR, LLC, James E. Besser, and Morgan C. Frank continue to hold significant, yet passive, beneficial ownership in NeuroOne Medical Technologies Corp., with all reported stakes remaining below the 5% threshold.
Summary
- Manchester Explorer, L.P. beneficially owns 1,333,333 shares, representing 4.1% of NeuroOne Medical Technologies Corp.'s common stock.
- Manchester Management Company, LLC beneficially owns 1,499,999 shares, representing 4.6% of the common stock.
- Manchester Management PR, LLC beneficially owns 1,499,999 shares, representing 4.6% of the common stock.
- James E. Besser beneficially owns 1,583,332 shares, representing 4.9% of the common stock, with both sole and shared voting/dispositive power.
- Morgan C. Frank beneficially owns 1,416,666 shares, representing 4.4% of the common stock, with both sole and shared voting/dispositive power.
- All reporting persons explicitly state that the securities were not acquired and are not held for the purpose of changing or influencing the control of the issuer, classifying them as passive investors under Rule 13d-1(b).
Sentiment
Score: 5
Explanation: The filing is a routine disclosure of passive beneficial ownership and does not contain information directly impacting company performance, strategy, or financial health. It is purely informational regarding shareholder stakes.
Future Outlook
NA
Industry Context
This filing is a standard disclosure of beneficial ownership by passive investors, common across all industries for publicly traded companies. It provides transparency regarding significant, non-controlling stakes held by investment entities and individuals.
Stakeholder Impact
- Shareholders: Provides transparency regarding significant, passive ownership stakes held by certain entities and individuals, confirming their non-controlling interest.
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date of event which requires filing of this statement |
| 02/14/2025 | Date of signing for Manchester Explorer, L.P., Manchester Management Company, LLC, Manchester Management PR, LLC, and James E. Besser |
| 02/14/2025 | Date of signing for Morgan C. Frank |
Keywords
SEC filing, Schedule 13G, Beneficial Ownership, NeuroOne Medical Technologies Corp, Passive Investment, Shareholding Disclosure, Institutional Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.